Real-World Outcomes In Patients With Chronic Hepatitis C Virus Infection And Substance Abuse Disorders Treated With Glecaprevir/Pibrentasvir For 8 Weeks: A Pooled Analysis Of Multinational Post-Marketing Observational Studies
AuthID
P-00S-ZQP
P-00S-ZQP